As of the close on February 6, 2024, Bafna Pharmaceuticals Limited's stock has gained approximately 1.56% over the past 52 weeks. The 50-day moving average sits at 97.34, while the 200-day moving average is 96.71.
| 52-Week Price Change | 1.56% |
| 50-Day Moving Average | 97.34 |
| 200-Day Moving Average | 96.71 |
Bafna Pharmaceuticals Limited's most recent stock split took place on August 26, 2019 with a 10:1 split ratio.
| Last Split Date | 8/26/2019 |
| Split Ratio | 10:1 |
Already premium?